Welcome to Vivacelle Bio Inc., a clinical stage biotechnology company focused on saving lives through innovative medical solutions. We specialize in the correction of hypovolemia, a life-threatening condition characterized by a drop in blood pressure. Our groundbreaking approach to fluid resuscitation is based on our patented phospholipid nanoparticle technology.

Using naturally-occurring phospholipids, we create small particles called micelles and liposomes, each with unique properties beneficial in specific critical illness scenarios. These particles form a protective layer around critical components, ensuring their delivery and effectiveness. Vivacelle Bio Inc.

Our products have undergone rigorous testing, allowing us to skip phase I due to their proven safety. Our commitment to advancing medical solutions and improving patient outcomes drives us to push boundaries and revolutionize fluid resuscitation. Join us on our mission to save lives and discover a new paradigm in critical care with Vivacelle Bio Inc